Orphan Drugs- development trends and strategies

The development of pharma industries has slowed in recent years because of many reasons such as patent expiries, generic competition, drying pipelines, and increasingly stringent regulatory guidelines. Many blockbuster drugs will lose their exclusivity in next 5 years. Therefore, the current economic situation plus the huge generic competition shifted the focus of pharmaceutical companies from the essential medicines to the new business model — niche busters, also called orphan drugs.

    Related Conference of Orphan Drugs- development trends and strategies

    September 23-24, 2019

    11th Euro-Global Conference on Infectious Diseases

    London, UK

    Venue: Park Inn by Radisson Hotel & Conference Centre London Heathrow
    September 23-24, 2019

    8th International Conference on Tropical Medicine and Infectious Diseases

    | ANA Crowne Plaza, Narita | Tokyo, Japan
    October 07-08, 2019

    5th Annual Congress on Infectious Diseases

    Frankfurt, Germany
    October 21-22, 2019

    15th World Congress on Infection Prevention and Control

    ZURICH | SWITZERLAND

    Venue: Mövenpick Hotel Zürich Airport
    November 25-26, 2019

    2nd World Congress on Rare Diseases

    Dubai, UAE
    January 27-28, 2020

    3rd Global Experts Meeting on Infectious Diseases

    | Bangkok, Thailand
    Feb 24-25, 2020

    7th International Congress on Infectious Diseases

    Berlin, Germany
    March 11-12, 2020

    8th International Conference on HIV AIDS STD & STIs

    Barcelona, Spain
    May 18-19, 2020

    7th Global Congress on Rare Diseases & Orphan Drug

    Istanbul, Turkey
    July 22-23, 2020

    10th World Congress on Rare Diseases and Orphan Drugs

    Barcelona, Spain
    December 06-07, 2021

    3rd World Congress on Rare Diseases

    Dubai, UAE

    Orphan Drugs- development trends and strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in